Description
Genomic Health 09-060: A real-world observational study to provide prospective information on the management of patients with metastatic castration-resistant prostate cancer (mCRPC) with disease progression after at least one line of androgen receptor-targeted therapy (ARTT) and the use of the Oncotype DX AR-V7 Nucleus Detect® assay in subsequent management
Location: SIMR (Sacramento/Valley Area)
Please contact: Kirsten Babski babskik@sutterhealth.org about study Genomic Health Oncotype DX AR-V7
Principal Investigator
Co-Investigator(s)
Vijay Suhag, M.D., Brian K. Kim, M.D, Sivakumar Reddy, M.D., Rajeswari Chellappah, M.D., Kristie A. Bobolis, M.D., Nitin Rohatgi, MD, Kristin N. Arreola, M.D.
Recruitment Status
Active, Recruiting
Start Date
May 20, 2020